Experience counts.

Our management team is a group of pharmaceutical research and marketing communications professionals who have been defining how health care professionals, patients, and payers understand brands in managed markets for decades. Together, their experience continues inspire and enlighten.

Paul Allen
Mr. Allen’s experience spans contributions to growth for companies including Clarkson Consulting, Novo Nordisk, IMS Health, Genactis and Olson Research Group. His research background makes him uniquely suited to take an objective approach to an opportunity in the marketplace, and succinctly uncover perceptions and drivers that inform how a brand will best succeed.

Rich Weiss
With 22 years experience working for pharmaceutical companies and 11 years consulting in managed markets, Mr. Weiss knows well the barriers to a brand’s success. He spearheaded managed care marketing of new product launches and disease management initiatives at Parke-Davis and directed Customer marketing and Long Term Care business and launched several new products into Managed Markets at Sandoz. While with DuPont, Rich initiated one of the industry’s first National Accounts Groups and implemented a fully automated Chargeback system.

Gary Bazalo
Mr. Bazalo is another team member who is a veteran of the pharmaceutical industry. His responsibilities have included managed care marketing of all products as Executive Director at Sandoz, Group Product Director and Product Manager in CNS and other markets, and head of data processing for clinical research. Gary has worked as a consultant in managed care contracting strategy, systems, pricing, market research, business planning, health economics modeling, and field laptop computer software.

Mark Iorio
Mr. Iorio is a well-versed pharmaceutical marketing communications professional with more than two decades of experience in planning, developing strategy, and implementing programs for internal and external audiences in managed markets. Clients have included Novo Nordisk, Bristol-Myers Squibb, and Otsuka Pharmaceutical Company. With a strong allegiance to research findings, Mark believes strongly that only well informed tactics will be successful in growing share of mind, and ultimately, share of market.